StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.90+0.14 (+3.72%)

Close on Nov 18, 2026Market cap $94.48MP/E –Yield –

Exagen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Exagen's market cap was $121.81M on Nov 11, 2026, against $177.83M a year earlier. Over the last 5 years it ranged from $23.62M to $256.73M, with a median of $69.56M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$121.81M-11.0%
2025Dec 31, 2025$136.86M+90.5%
2024Dec 31, 2024$71.83M+113.2%
2023Dec 29, 2023$33.69M-13.9%
2022Dec 30, 2022$39.13M-79.2%
2021Dec 31, 2021$187.99M+12.6%
2020Dec 31, 2020$167.01M-47.6%
2019Dec 31, 2019$319.01M–

More Exagen figures

See a number that looks wrong?